Document is current
Any future updates will be listed below
-
Authors
Schein, Jeff
Cloutier, Martin
Gauthier-Loiselle, Marjolaine
Catillon, Maryaline https://orcid.org/0000-0002-1360-8133
Meng, Yan
Libchaber, Beatrice
Jiang, Fanny
Childress, Ann
-
Funding
Funding for this research was provided by:
Otsuka Pharmaceutical Development and Commercialization
- License Information
-
More Information
Article History
Received: 11 July 2024
Accepted: 23 October 2024
First Online: 16 November 2024
Declarations
:
: Jeff Schein is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. Martin Cloutier, Marjolaine Gauthier-Loiselle, Maryaline Catillon, Yan Meng, Beatrice Libchaber, and Fanny Jiang are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Otsuka Pharmaceutical Development & Commercialization, Inc. Ann Childress received research support from Aardvark, Allergan, Axsome, Emalex, Akili, Cingulate, Corium, Ironshore, Les Laboratoires Servier, Lumos, Neurocentria, Otsuka, Purdue, Adlon, Sunovion, Tris, KemPharm, and Supernus; was on the advisory board of Corium, Otsuka, Tris, and Supernus; received consulting fees from Aardvark, Alora, Axsome, Aytu, Cingulate, Corium, Lumos, Medison Pharma, Neurocentria, Noven, Otsuka, Tris, KemPharm, Supernus, and Tulex; received speaker fees from Takeda, Corium, Ironshore, Tris, and Supernus; and received writing support from Otsuka, Takeda, Corium, Ironshore, Purdue, and Tris.
: The study was approved by the Western Copernicus Group (WCG) Institutional Review Board (IRB; IRB number 20233279). The study is in accordance with the Declaration of Helsinki.
